John Carroll
Concepts (393)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carotid Body | 26 | 2015 | 43 | 7.690 |
Why?
| Chemoreceptor Cells | 14 | 2023 | 23 | 3.080 |
Why?
| Oocytes | 4 | 2022 | 74 | 2.450 |
Why?
| Potassium Channels, Tandem Pore Domain | 7 | 2015 | 12 | 2.250 |
Why?
| Calcium | 9 | 2015 | 397 | 2.010 |
Why?
| Hyperoxia | 8 | 2023 | 26 | 1.980 |
Why?
| Respiration, Artificial | 10 | 2024 | 265 | 1.650 |
Why?
| Oxygen | 10 | 2012 | 325 | 1.450 |
Why?
| Mitochondria | 6 | 2022 | 397 | 1.330 |
Why?
| Rats | 19 | 2015 | 3300 | 1.000 |
Why?
| Cell Hypoxia | 5 | 2013 | 82 | 0.970 |
Why?
| Membrane Potentials | 8 | 2015 | 117 | 0.960 |
Why?
| Respiration Disorders | 3 | 2023 | 23 | 0.950 |
Why?
| Lysosomes | 1 | 2024 | 64 | 0.940 |
Why?
| Animals, Newborn | 15 | 2015 | 366 | 0.940 |
Why?
| Animals | 34 | 2024 | 13150 | 0.920 |
Why?
| Embryonic Development | 1 | 2022 | 17 | 0.830 |
Why?
| Fertility | 1 | 2022 | 28 | 0.810 |
Why?
| Lung Diseases | 3 | 2019 | 93 | 0.770 |
Why?
| Infant, Extremely Premature | 4 | 2024 | 34 | 0.740 |
Why?
| Nerve Tissue Proteins | 7 | 2015 | 193 | 0.730 |
Why?
| Hydrogen Peroxide | 1 | 2021 | 114 | 0.730 |
Why?
| Aortic Valve Stenosis | 4 | 2024 | 60 | 0.720 |
Why?
| Patch-Clamp Techniques | 7 | 2015 | 124 | 0.650 |
Why?
| Cystic Fibrosis | 3 | 2015 | 147 | 0.620 |
Why?
| Sleep Apnea Syndromes | 4 | 2023 | 29 | 0.610 |
Why?
| Rats, Sprague-Dawley | 10 | 2015 | 1595 | 0.600 |
Why?
| Home Care Services | 4 | 2023 | 73 | 0.600 |
Why?
| Humans | 57 | 2024 | 49827 | 0.600 |
Why?
| Sleep Apnea, Obstructive | 5 | 2018 | 66 | 0.580 |
Why?
| Infant, Premature | 7 | 2023 | 308 | 0.570 |
Why?
| Adenosine Triphosphate | 3 | 2013 | 234 | 0.560 |
Why?
| Tracheostomy | 2 | 2023 | 75 | 0.550 |
Why?
| Health Personnel | 2 | 2015 | 241 | 0.520 |
Why?
| Hydrogen Sulfide | 1 | 2015 | 5 | 0.520 |
Why?
| Transient Receptor Potential Channels | 1 | 2015 | 3 | 0.500 |
Why?
| Transition to Adult Care | 1 | 2015 | 17 | 0.500 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 76 | 0.500 |
Why?
| Respiratory Therapy | 1 | 2015 | 34 | 0.490 |
Why?
| Enzyme Inhibitors | 2 | 2014 | 391 | 0.480 |
Why?
| AMP-Activated Protein Kinases | 1 | 2014 | 30 | 0.470 |
Why?
| Electron Transport Complex IV | 1 | 2013 | 25 | 0.460 |
Why?
| Child | 20 | 2020 | 6824 | 0.450 |
Why?
| Pediatrics | 2 | 2016 | 277 | 0.450 |
Why?
| Piperidines | 3 | 2021 | 97 | 0.440 |
Why?
| Female | 35 | 2024 | 26329 | 0.440 |
Why?
| Sleep | 5 | 2021 | 182 | 0.430 |
Why?
| Staphylococcal Infections | 1 | 2015 | 269 | 0.430 |
Why?
| Clinical Competence | 1 | 2015 | 398 | 0.420 |
Why?
| Neural Conduction | 3 | 2009 | 34 | 0.420 |
Why?
| Analysis of Variance | 6 | 2015 | 565 | 0.400 |
Why?
| Bronchopulmonary Dysplasia | 3 | 2023 | 70 | 0.400 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 488 | 0.390 |
Why?
| Potassium Channels, Inwardly Rectifying | 1 | 2011 | 7 | 0.390 |
Why?
| Infant, Newborn | 14 | 2024 | 2744 | 0.390 |
Why?
| Osteogenesis Imperfecta | 2 | 2022 | 38 | 0.380 |
Why?
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2011 | 12 | 0.380 |
Why?
| Collagen Type I | 2 | 2022 | 89 | 0.370 |
Why?
| Pulmonary Ventilation | 1 | 2010 | 11 | 0.370 |
Why?
| Mechanotransduction, Cellular | 1 | 2011 | 36 | 0.370 |
Why?
| Aging | 3 | 2004 | 688 | 0.360 |
Why?
| Infant | 15 | 2023 | 3551 | 0.350 |
Why?
| Male | 29 | 2024 | 25093 | 0.330 |
Why?
| Signal Transduction | 2 | 2005 | 1617 | 0.320 |
Why?
| Respiration | 6 | 2024 | 96 | 0.320 |
Why?
| Time Factors | 8 | 2024 | 2912 | 0.310 |
Why?
| Receptors, Dopamine D2 | 2 | 2005 | 16 | 0.310 |
Why?
| Infant, Premature, Diseases | 3 | 2024 | 94 | 0.310 |
Why?
| Apnea | 2 | 2024 | 18 | 0.290 |
Why?
| Bradycardia | 2 | 2024 | 36 | 0.290 |
Why?
| Age Factors | 6 | 2024 | 1090 | 0.290 |
Why?
| Neurotransmitter Agents | 2 | 2009 | 34 | 0.280 |
Why?
| Chronic Disease | 5 | 2019 | 563 | 0.280 |
Why?
| Sleep Stages | 3 | 2011 | 45 | 0.270 |
Why?
| United States | 10 | 2024 | 4838 | 0.270 |
Why?
| Registries | 5 | 2024 | 518 | 0.270 |
Why?
| Delivery of Health Care | 2 | 2019 | 307 | 0.260 |
Why?
| Polysomnography | 8 | 2015 | 71 | 0.260 |
Why?
| Continuous Positive Airway Pressure | 2 | 2018 | 56 | 0.260 |
Why?
| Pregnancy | 5 | 2022 | 2584 | 0.260 |
Why?
| Hospitals, Pediatric | 3 | 2015 | 239 | 0.260 |
Why?
| Patient Discharge | 2 | 2019 | 322 | 0.260 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2004 | 12 | 0.250 |
Why?
| Potassium | 1 | 2004 | 57 | 0.250 |
Why?
| Fertilization | 1 | 2024 | 6 | 0.250 |
Why?
| Ovum | 1 | 2024 | 6 | 0.250 |
Why?
| Foramen Ovale, Patent | 1 | 2024 | 27 | 0.230 |
Why?
| Reactive Oxygen Species | 2 | 2022 | 408 | 0.230 |
Why?
| Cells, Cultured | 4 | 2020 | 1571 | 0.230 |
Why?
| Pyridines | 1 | 2004 | 130 | 0.230 |
Why?
| Oximes | 2 | 2021 | 11 | 0.220 |
Why?
| Movement | 2 | 2021 | 82 | 0.220 |
Why?
| Sleep Apnea, Central | 1 | 2003 | 12 | 0.220 |
Why?
| Respiratory Muscles | 1 | 2003 | 5 | 0.220 |
Why?
| DNA, Mitochondrial | 2 | 2022 | 112 | 0.220 |
Why?
| Respiratory System | 1 | 2003 | 26 | 0.220 |
Why?
| Heart Rate | 1 | 2024 | 292 | 0.210 |
Why?
| Patient Selection | 1 | 2024 | 251 | 0.210 |
Why?
| Dynamins | 1 | 2022 | 6 | 0.210 |
Why?
| Neuronal Plasticity | 1 | 2003 | 58 | 0.210 |
Why?
| Feasibility Studies | 1 | 2024 | 374 | 0.210 |
Why?
| Ehlers-Danlos Syndrome | 1 | 2022 | 6 | 0.210 |
Why?
| Oogenesis | 1 | 2022 | 16 | 0.210 |
Why?
| Cytoplasm | 1 | 2022 | 90 | 0.200 |
Why?
| Intracellular Space | 2 | 2014 | 25 | 0.200 |
Why?
| Catecholamines | 2 | 2013 | 46 | 0.200 |
Why?
| Dose-Response Relationship, Drug | 3 | 2015 | 1374 | 0.200 |
Why?
| In Vitro Oocyte Maturation Techniques | 1 | 2021 | 1 | 0.190 |
Why?
| Sepsis | 1 | 2024 | 220 | 0.190 |
Why?
| Risk Factors | 9 | 2024 | 3619 | 0.190 |
Why?
| Australia | 1 | 2021 | 83 | 0.190 |
Why?
| Posture | 1 | 2020 | 59 | 0.180 |
Why?
| Electrophysiology | 2 | 2011 | 78 | 0.180 |
Why?
| Mice | 5 | 2022 | 5720 | 0.180 |
Why?
| Ventilators, Mechanical | 1 | 2020 | 43 | 0.180 |
Why?
| Respiratory Mechanics | 2 | 2018 | 36 | 0.170 |
Why?
| Prisoners | 1 | 2021 | 87 | 0.170 |
Why?
| Extracellular Matrix Proteins | 1 | 2020 | 69 | 0.170 |
Why?
| Molecular Chaperones | 1 | 2020 | 64 | 0.170 |
Why?
| Action Potentials | 2 | 2013 | 133 | 0.170 |
Why?
| RNA, Messenger | 4 | 2011 | 1105 | 0.170 |
Why?
| Tertiary Care Centers | 2 | 2018 | 77 | 0.170 |
Why?
| Stroke | 1 | 2024 | 492 | 0.160 |
Why?
| Nitric Oxide | 2 | 2011 | 253 | 0.160 |
Why?
| Plethysmography | 1 | 2018 | 43 | 0.160 |
Why?
| Child, Preschool | 8 | 2018 | 3853 | 0.160 |
Why?
| Disease Models, Animal | 4 | 2022 | 1451 | 0.160 |
Why?
| Ion Channel Gating | 2 | 2011 | 39 | 0.160 |
Why?
| Membrane Potential, Mitochondrial | 2 | 2015 | 38 | 0.160 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2011 | 138 | 0.160 |
Why?
| Adolescent | 10 | 2018 | 6340 | 0.150 |
Why?
| Spirometry | 1 | 2018 | 29 | 0.150 |
Why?
| Retrospective Studies | 7 | 2024 | 6117 | 0.150 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 595 | 0.150 |
Why?
| Treatment Outcome | 7 | 2024 | 5138 | 0.150 |
Why?
| Aortic Valve | 3 | 2024 | 113 | 0.150 |
Why?
| KCNQ2 Potassium Channel | 1 | 2017 | 9 | 0.140 |
Why?
| Myoclonus | 1 | 2017 | 9 | 0.140 |
Why?
| Opioid-Related Disorders | 1 | 2021 | 375 | 0.140 |
Why?
| Spasms, Infantile | 1 | 2017 | 27 | 0.140 |
Why?
| Obesity | 2 | 2015 | 1113 | 0.140 |
Why?
| Aged | 4 | 2024 | 9272 | 0.140 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2017 | 485 | 0.140 |
Why?
| Length of Stay | 1 | 2019 | 623 | 0.140 |
Why?
| Hospitals, Special | 1 | 2016 | 9 | 0.130 |
Why?
| Molecular Typing | 1 | 2015 | 10 | 0.130 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 29 | 0.130 |
Why?
| Patient Care Team | 2 | 2015 | 255 | 0.130 |
Why?
| Pseudomonas Infections | 1 | 2015 | 48 | 0.130 |
Why?
| Arteries | 2 | 2009 | 94 | 0.130 |
Why?
| Manikins | 1 | 2015 | 35 | 0.130 |
Why?
| Pseudomonas aeruginosa | 1 | 2015 | 72 | 0.130 |
Why?
| Alkynes | 1 | 2015 | 5 | 0.130 |
Why?
| Coinfection | 1 | 2015 | 38 | 0.130 |
Why?
| Intracellular Fluid | 1 | 2015 | 12 | 0.130 |
Why?
| Sodium Compounds | 1 | 2015 | 11 | 0.130 |
Why?
| DNA, Bacterial | 1 | 2015 | 185 | 0.130 |
Why?
| Risk Assessment | 3 | 2015 | 1262 | 0.130 |
Why?
| Patient Safety | 1 | 2015 | 101 | 0.130 |
Why?
| Boron Compounds | 1 | 2015 | 19 | 0.120 |
Why?
| NAD | 1 | 2015 | 43 | 0.120 |
Why?
| RNA | 2 | 2006 | 170 | 0.120 |
Why?
| Glycine | 1 | 2015 | 75 | 0.120 |
Why?
| Computer Simulation | 1 | 2015 | 282 | 0.120 |
Why?
| Tacrolimus | 1 | 2015 | 51 | 0.120 |
Why?
| Mutation | 3 | 2022 | 1293 | 0.120 |
Why?
| Polymerase Chain Reaction | 1 | 2015 | 455 | 0.120 |
Why?
| Genotype | 1 | 2015 | 538 | 0.120 |
Why?
| Foreign Bodies | 1 | 2015 | 65 | 0.120 |
Why?
| Aminoimidazole Carboxamide | 1 | 2014 | 3 | 0.120 |
Why?
| Ribonucleotides | 1 | 2014 | 5 | 0.120 |
Why?
| Disease Management | 1 | 2015 | 174 | 0.120 |
Why?
| Pyrones | 1 | 2014 | 8 | 0.120 |
Why?
| Enzyme Activators | 1 | 2014 | 8 | 0.120 |
Why?
| PC12 Cells | 1 | 2014 | 24 | 0.120 |
Why?
| Reference Values | 3 | 2011 | 310 | 0.120 |
Why?
| Biphenyl Compounds | 1 | 2014 | 30 | 0.120 |
Why?
| Sodium Cyanide | 1 | 2013 | 2 | 0.120 |
Why?
| Forced Expiratory Volume | 1 | 2014 | 44 | 0.120 |
Why?
| Thiophenes | 1 | 2014 | 36 | 0.120 |
Why?
| Respiratory Distress Syndrome, Newborn | 2 | 2011 | 52 | 0.110 |
Why?
| Cardiac Catheterization | 1 | 2015 | 196 | 0.110 |
Why?
| Rural Population | 1 | 2018 | 535 | 0.110 |
Why?
| Quality of Health Care | 1 | 2015 | 185 | 0.110 |
Why?
| Prospective Studies | 4 | 2024 | 2344 | 0.110 |
Why?
| Referral and Consultation | 1 | 2015 | 287 | 0.110 |
Why?
| Colostomy | 1 | 2012 | 11 | 0.110 |
Why?
| Prevalence | 1 | 2015 | 943 | 0.110 |
Why?
| Patient Advocacy | 1 | 2012 | 14 | 0.100 |
Why?
| Pediatric Nursing | 1 | 2012 | 15 | 0.100 |
Why?
| Phosphorylation | 1 | 2014 | 536 | 0.100 |
Why?
| Administration, Intravenous | 1 | 2012 | 68 | 0.100 |
Why?
| Receptors, Purinergic P2Y12 | 1 | 2012 | 12 | 0.100 |
Why?
| Multicenter Studies as Topic | 2 | 2022 | 84 | 0.100 |
Why?
| Nocturnal Myoclonus Syndrome | 1 | 2011 | 13 | 0.100 |
Why?
| Narcolepsy | 1 | 2011 | 12 | 0.100 |
Why?
| Receptors, Purinergic P2 | 1 | 2012 | 39 | 0.100 |
Why?
| Patient Compliance | 1 | 2013 | 230 | 0.100 |
Why?
| Telemedicine | 1 | 2018 | 443 | 0.100 |
Why?
| Disabled Children | 1 | 2012 | 63 | 0.100 |
Why?
| Respiratory Physiological Phenomena | 2 | 2019 | 10 | 0.100 |
Why?
| Cyanides | 1 | 2011 | 5 | 0.100 |
Why?
| Glyburide | 1 | 2011 | 6 | 0.100 |
Why?
| Receptors, Drug | 1 | 2011 | 4 | 0.100 |
Why?
| Biophysics | 1 | 2011 | 16 | 0.100 |
Why?
| Diazoxide | 1 | 2011 | 6 | 0.100 |
Why?
| KATP Channels | 1 | 2011 | 6 | 0.100 |
Why?
| Sweetening Agents | 1 | 2011 | 23 | 0.100 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2011 | 34 | 0.100 |
Why?
| Supine Position | 2 | 2021 | 26 | 0.100 |
Why?
| Electric Stimulation | 1 | 2011 | 116 | 0.100 |
Why?
| Prone Position | 2 | 2021 | 29 | 0.100 |
Why?
| Ataxia Telangiectasia | 1 | 2010 | 6 | 0.090 |
Why?
| Bronchiectasis | 1 | 2010 | 9 | 0.090 |
Why?
| Rubinstein-Taybi Syndrome | 1 | 2010 | 3 | 0.090 |
Why?
| Vasodilator Agents | 1 | 2011 | 97 | 0.090 |
Why?
| Lung Diseases, Interstitial | 1 | 2010 | 23 | 0.090 |
Why?
| Electromyography | 2 | 2021 | 131 | 0.090 |
Why?
| Medicare | 2 | 2022 | 244 | 0.090 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2010 | 35 | 0.090 |
Why?
| Carbon Dioxide | 1 | 2010 | 90 | 0.090 |
Why?
| Arkansas | 1 | 2016 | 1967 | 0.090 |
Why?
| Blood Pressure | 3 | 2005 | 514 | 0.090 |
Why?
| Bronchodilator Agents | 1 | 2010 | 73 | 0.090 |
Why?
| Deglutition Disorders | 2 | 2010 | 77 | 0.090 |
Why?
| Glossopharyngeal Nerve | 1 | 2009 | 2 | 0.090 |
Why?
| Hypoglycemic Agents | 1 | 2011 | 166 | 0.090 |
Why?
| Potassium Chloride | 1 | 2009 | 20 | 0.090 |
Why?
| Ruthenium Red | 1 | 2009 | 5 | 0.090 |
Why?
| Isomerism | 1 | 2009 | 22 | 0.080 |
Why?
| Potassium Channel Blockers | 1 | 2009 | 16 | 0.080 |
Why?
| Crohn Disease | 1 | 2010 | 89 | 0.080 |
Why?
| Arachidonic Acids | 1 | 2009 | 22 | 0.080 |
Why?
| Magnesium | 1 | 2009 | 35 | 0.080 |
Why?
| Coloring Agents | 1 | 2009 | 71 | 0.080 |
Why?
| Glucose | 1 | 2011 | 340 | 0.080 |
Why?
| Lung | 2 | 2022 | 480 | 0.080 |
Why?
| HeLa Cells | 1 | 2009 | 251 | 0.080 |
Why?
| Gene Expression Regulation | 1 | 2012 | 979 | 0.070 |
Why?
| Diagnosis, Differential | 2 | 2015 | 1036 | 0.070 |
Why?
| Parents | 2 | 2012 | 312 | 0.070 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2024 | 553 | 0.070 |
Why?
| Quinpirole | 1 | 2005 | 2 | 0.060 |
Why?
| Sulpiride | 1 | 2005 | 3 | 0.060 |
Why?
| Dopamine Agonists | 1 | 2005 | 8 | 0.060 |
Why?
| Mountaineering | 1 | 2005 | 2 | 0.060 |
Why?
| Dopamine Antagonists | 1 | 2005 | 20 | 0.060 |
Why?
| Acclimatization | 1 | 2005 | 17 | 0.060 |
Why?
| Medulla Oblongata | 2 | 1995 | 21 | 0.060 |
Why?
| Fetal Diseases | 1 | 2005 | 62 | 0.060 |
Why?
| Follow-Up Studies | 4 | 2015 | 2179 | 0.060 |
Why?
| Ventricular Dysfunction, Left | 1 | 2005 | 92 | 0.060 |
Why?
| Oxygen Consumption | 1 | 2005 | 180 | 0.060 |
Why?
| Medical History Taking | 1 | 2004 | 47 | 0.060 |
Why?
| Circadian Rhythm | 1 | 2004 | 87 | 0.060 |
Why?
| Snoring | 1 | 2003 | 9 | 0.060 |
Why?
| Physical Examination | 1 | 2004 | 90 | 0.060 |
Why?
| Gene Expression | 1 | 2006 | 608 | 0.060 |
Why?
| Receptors, Dopamine D1 | 1 | 2003 | 7 | 0.050 |
Why?
| Reflex | 1 | 2003 | 31 | 0.050 |
Why?
| International Cooperation | 1 | 2003 | 44 | 0.050 |
Why?
| Aged, 80 and over | 2 | 2024 | 3125 | 0.050 |
Why?
| Intensive Care Units, Neonatal | 1 | 2024 | 110 | 0.050 |
Why?
| Nervous System | 1 | 2003 | 33 | 0.050 |
Why?
| X-Ray Microtomography | 1 | 2022 | 77 | 0.050 |
Why?
| Hospitals | 1 | 2024 | 175 | 0.050 |
Why?
| Collagen Type V | 1 | 2022 | 4 | 0.050 |
Why?
| Haploinsufficiency | 1 | 2022 | 13 | 0.050 |
Why?
| Recurrence | 1 | 2024 | 651 | 0.050 |
Why?
| Gestational Age | 1 | 2024 | 417 | 0.050 |
Why?
| Respiratory Function Tests | 2 | 2014 | 90 | 0.050 |
Why?
| Adult | 2 | 2015 | 13160 | 0.050 |
Why?
| Pharynx | 2 | 2015 | 33 | 0.050 |
Why?
| Fetus | 1 | 2003 | 217 | 0.050 |
Why?
| Injections, Intramuscular | 1 | 2021 | 54 | 0.050 |
Why?
| Delayed-Action Preparations | 1 | 2021 | 47 | 0.050 |
Why?
| Prisons | 1 | 2021 | 38 | 0.050 |
Why?
| Naltrexone | 1 | 2021 | 58 | 0.050 |
Why?
| Collagen | 1 | 2022 | 206 | 0.050 |
Why?
| Algorithms | 1 | 2024 | 616 | 0.050 |
Why?
| Administration, Inhalation | 2 | 2011 | 107 | 0.050 |
Why?
| Incidence | 2 | 2015 | 1003 | 0.050 |
Why?
| Ventilator Weaning | 1 | 2020 | 19 | 0.050 |
Why?
| Oxidative Stress | 1 | 2005 | 768 | 0.040 |
Why?
| Narcotic Antagonists | 1 | 2021 | 130 | 0.040 |
Why?
| Intensive Care Units | 1 | 2020 | 210 | 0.040 |
Why?
| Protein Processing, Post-Translational | 1 | 2020 | 171 | 0.040 |
Why?
| Clinical Protocols | 1 | 2019 | 108 | 0.040 |
Why?
| Monitoring, Physiologic | 1 | 2019 | 121 | 0.040 |
Why?
| Statistics, Nonparametric | 2 | 2011 | 197 | 0.040 |
Why?
| Histidine | 1 | 2017 | 15 | 0.040 |
Why?
| Community Health Services | 1 | 2018 | 101 | 0.040 |
Why?
| Mice, Knockout | 1 | 2020 | 841 | 0.040 |
Why?
| Quality Assurance, Health Care | 1 | 2018 | 149 | 0.040 |
Why?
| Cysteine | 1 | 2017 | 49 | 0.040 |
Why?
| Research Design | 1 | 2019 | 343 | 0.040 |
Why?
| Models, Statistical | 1 | 2018 | 225 | 0.030 |
Why?
| Societies | 1 | 2016 | 7 | 0.030 |
Why?
| Pilot Projects | 1 | 2018 | 699 | 0.030 |
Why?
| Anticonvulsants | 1 | 2017 | 122 | 0.030 |
Why?
| Analgesics, Opioid | 1 | 2021 | 532 | 0.030 |
Why?
| Quality Improvement | 1 | 2018 | 212 | 0.030 |
Why?
| Arginine | 1 | 2017 | 179 | 0.030 |
Why?
| Palate | 1 | 2015 | 12 | 0.030 |
Why?
| Uvula | 1 | 2015 | 14 | 0.030 |
Why?
| Cinnamates | 1 | 2015 | 2 | 0.030 |
Why?
| Thiourea | 1 | 2015 | 9 | 0.030 |
Why?
| Bronchography | 1 | 2015 | 6 | 0.030 |
Why?
| Adenoidectomy | 1 | 2015 | 35 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2011 | 942 | 0.030 |
Why?
| Electroencephalography | 1 | 2017 | 306 | 0.030 |
Why?
| Bronchi | 1 | 2015 | 43 | 0.030 |
Why?
| Afferent Pathways | 1 | 1994 | 12 | 0.030 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2015 | 36 | 0.030 |
Why?
| Tonsillectomy | 1 | 2015 | 49 | 0.030 |
Why?
| Hypoxia, Brain | 1 | 1994 | 15 | 0.030 |
Why?
| Respiratory Sounds | 1 | 2015 | 47 | 0.030 |
Why?
| Cough | 1 | 2015 | 54 | 0.030 |
Why?
| Bronchoscopy | 1 | 2015 | 71 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2020 | 1806 | 0.030 |
Why?
| Phenotype | 1 | 2017 | 727 | 0.030 |
Why?
| Caregivers | 1 | 2016 | 206 | 0.030 |
Why?
| Staff Development | 1 | 2013 | 23 | 0.030 |
Why?
| Seizures | 1 | 2015 | 196 | 0.030 |
Why?
| Professional-Patient Relations | 1 | 2013 | 47 | 0.030 |
Why?
| Professional Role | 1 | 2013 | 76 | 0.030 |
Why?
| Survival Rate | 1 | 2015 | 905 | 0.030 |
Why?
| Ambulatory Care Facilities | 1 | 2013 | 125 | 0.030 |
Why?
| Social Isolation | 1 | 2012 | 28 | 0.030 |
Why?
| Professional-Family Relations | 1 | 2012 | 44 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2015 | 971 | 0.030 |
Why?
| Sleep, REM | 1 | 2011 | 44 | 0.030 |
Why?
| Ambulatory Care | 1 | 2013 | 222 | 0.020 |
Why?
| Sex Distribution | 1 | 2011 | 135 | 0.020 |
Why?
| Age Distribution | 1 | 2011 | 170 | 0.020 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2011 | 6 | 0.020 |
Why?
| Potassium Channels | 1 | 2011 | 31 | 0.020 |
Why?
| Schools | 1 | 2012 | 165 | 0.020 |
Why?
| Emotions | 1 | 2012 | 165 | 0.020 |
Why?
| Calcium Signaling | 1 | 2011 | 56 | 0.020 |
Why?
| Social Support | 1 | 2012 | 265 | 0.020 |
Why?
| Patient Education as Topic | 1 | 2013 | 295 | 0.020 |
Why?
| Stress, Psychological | 1 | 2012 | 260 | 0.020 |
Why?
| Comorbidity | 1 | 2011 | 618 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2017 | 1533 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2015 | 1159 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2010 | 248 | 0.020 |
Why?
| Gene Deletion | 1 | 2010 | 266 | 0.020 |
Why?
| Middle Aged | 1 | 2024 | 11997 | 0.020 |
Why?
| Prognosis | 1 | 2014 | 1952 | 0.020 |
Why?
| Case-Control Studies | 1 | 2011 | 1128 | 0.020 |
Why?
| Postoperative Complications | 1 | 2015 | 1000 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2010 | 460 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2010 | 448 | 0.020 |
Why?
| Barium Sulfate | 1 | 2006 | 12 | 0.020 |
Why?
| Respiratory Aspiration | 1 | 2006 | 9 | 0.020 |
Why?
| Fluoroscopy | 1 | 2006 | 42 | 0.020 |
Why?
| Video Recording | 1 | 2006 | 80 | 0.020 |
Why?
| Cardiac Volume | 1 | 2005 | 6 | 0.020 |
Why?
| Contrast Media | 1 | 2006 | 183 | 0.020 |
Why?
| Diastole | 1 | 2005 | 69 | 0.020 |
Why?
| Carotid Sinus | 2 | 1995 | 5 | 0.020 |
Why?
| Denervation | 2 | 1995 | 20 | 0.020 |
Why?
| Systole | 1 | 2005 | 68 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2005 | 99 | 0.020 |
Why?
| Cats | 2 | 1995 | 79 | 0.020 |
Why?
| Mitral Valve | 1 | 2005 | 49 | 0.020 |
Why?
| Myocardial Contraction | 1 | 2005 | 105 | 0.020 |
Why?
| Oxyhemoglobins | 1 | 2004 | 4 | 0.010 |
Why?
| Blood Gas Analysis | 1 | 2004 | 30 | 0.010 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2004 | 36 | 0.010 |
Why?
| Ventricular Function, Left | 1 | 2005 | 154 | 0.010 |
Why?
| Arousal | 1 | 2004 | 98 | 0.010 |
Why?
| Ganglia, Sensory | 1 | 2003 | 1 | 0.010 |
Why?
| Superior Cervical Ganglion | 1 | 2003 | 7 | 0.010 |
Why?
| Corpus Striatum | 1 | 2003 | 50 | 0.010 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2003 | 74 | 0.010 |
Why?
| International Classification of Diseases | 1 | 2003 | 64 | 0.010 |
Why?
| Young Adult | 1 | 2011 | 3936 | 0.010 |
Why?
| Rabbits | 1 | 2003 | 370 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2003 | 376 | 0.010 |
Why?
| Echocardiography | 1 | 2005 | 378 | 0.010 |
Why?
| Body Mass Index | 1 | 2004 | 652 | 0.010 |
Why?
| Heart Failure | 1 | 2005 | 454 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2002 | 1188 | 0.010 |
Why?
| Vagotomy | 1 | 1995 | 5 | 0.010 |
Why?
| Nitroprusside | 1 | 1995 | 10 | 0.010 |
Why?
| Phenylephrine | 1 | 1995 | 34 | 0.010 |
Why?
| Optics and Photonics | 1 | 1995 | 12 | 0.010 |
Why?
| Light | 1 | 1995 | 70 | 0.010 |
Why?
| Tidal Volume | 1 | 1994 | 52 | 0.010 |
Why?
| Cerebral Cortex | 1 | 1995 | 200 | 0.010 |
Why?
| Electrocardiography | 1 | 1994 | 253 | 0.010 |
Why?
|
|
Carroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|